Literature DB >> 19563505

Angiogenic and lymphangiogenic microvessel density in recurrent pleomorphic adenoma.

Andresa B Soares1, Vera C de Araújo, Priscila B Juliano, Albina Altemani.   

Abstract

BACKGROUND: Recurrent pleomorphic adenoma (RPA) is an uncommon and challenging disease. The aim of this study was to determine if there is a difference between RPA and the pleomorphic adenoma (PA) without recurrence related to tumor blood and lymphatic vascularization. Moreover, we compared the microvessel density (MVD) between cell-rich areas (predominance of epithelial cells) and cell-poor areas (predominance of myxoid and chondroid areas) of the stroma of PA and RPA. In addition, immunohistochemical staining for the Ki-67 antigen was conducted simultaneously to evaluate cell proliferation in PA and RPA.
METHODS: A total of 19 cases of PA and 24 cases of RPA, blood, and lymphatic vessels were analyzed by immunohistochemical technique using the antibodies CD34, CD105, D2-40, and Ki-67.
RESULTS: Comparing no recurrent with recurrent tumor, no significant difference was found in terms of lymphatic vessel density, MVD, and proliferation index. When MVD and proliferation index were compared with different areas in cellular composition (cell-rich and cell-poor areas), there was a significant difference in PA, as well as in RPA.
CONCLUSION: This study shows that although RPA presents more aggressive clinical behavior than PA, there is no difference between tumor blood and lymphatic vascularization, suggesting that there is no correlation between vascularity and risk of recurrence. Furthermore, vascularized stroma in PA, as well as RPA, depends on the proportion of the cellular composition.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19563505     DOI: 10.1111/j.1600-0714.2009.00794.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  12 in total

1.  Assessment of CTNNB1 gene mutations and β-catenin immunoexpression in salivary gland pleomorphic adenomas and adenoid cystic carcinomas.

Authors:  Roberta Barroso Cavalcante; Cassiano Francisco Weege Nonaka; Hellen Bandeira de Pontes Santos; Silvia Helena Barem Rabenhorst; Leão Pereira Pinto; Lélia Batista de Souza
Journal:  Virchows Arch       Date:  2018-03-26       Impact factor: 4.064

2.  Solitary fibrous tumor with entrapment of minor salivary gland tissue: an unusual presentation that requires exclusion of pleomorphic adenoma.

Authors:  Jose Luis Tapia; Samuel Goodloe; Joseph E Margarone; Michael R Markiewicz; Alfredo Aguirre
Journal:  Head Neck Pathol       Date:  2011-03-19

3.  Pleomorphic adenoma with extensive squamous metaplasia and keratin cyst formations in minor salivary gland: a case report.

Authors:  Maria Carolina Vaz Goulart; Patrícia Freitas-Faria; Gláuter Rodrigues Goulart; Adriano Macedo de Oliveira; Roman Carlos-Bregni; Cleverson Teixeira Soares; Vanessa Soares Lara
Journal:  J Appl Oral Sci       Date:  2011-04       Impact factor: 2.698

4.  Differing Lymphatic Vessels Density in Salivary Adenoid Cystic Carcinoma and Pleomorphic Adenoma.

Authors:  Richard Salzman; I Stárek; L Kučerová; A Skálová
Journal:  Pathol Oncol Res       Date:  2016-11-11       Impact factor: 3.201

5.  Neither expression of VEGF-C/D nor lymph vessel density supports lymphatic invasion as the mechanism responsible for local spread of recurrent salivary pleomorphic adenoma.

Authors:  R Salzman; I Stárek; L Kučerová; A Skálová; J Hoza
Journal:  Virchows Arch       Date:  2014-01       Impact factor: 4.064

6.  PLAG1 expression is maintained in recurrent pleomorphic adenoma.

Authors:  Beatriz Samara de Brito; Natália Giovanelli Gaspar; Erika Said Abu Egal; Celeste Sanchez-Romero; Antonio Santos Martins; Álfio José Tincani; Rogério de Oliveira Gondak; Oslei Paes de Almeida; Luiz Paulo Kowalski; Albina Altemani; Fernanda Viviane Mariano
Journal:  Virchows Arch       Date:  2016-07-06       Impact factor: 4.064

7.  Immunohistochemical analysis of CD34 expression in salivary gland tumors.

Authors:  Saede Atarbashi Moghadam; Ayda Mohammad Abadi; Sepideh Mokhtari
Journal:  J Oral Maxillofac Pathol       Date:  2015 Jan-Apr

8.  Comparison of the blood and lymphatic microvessel density of pleomorphic adenoma and Basal cell adenoma.

Authors:  Andresa Borges Soares; Albina Altemani; Thais Ribeiro de Oliveira; Felipe de Oliveira Fonseca Rodrigues; Alfredo Ribeiro-Silva; Danilo Figueiredo Soave; Fabricio Passador-Santos; Suellen Trentin Brum; Marcelo Henrique Napimoga; Vera Cavalcanti de Araújo
Journal:  Clin Med Insights Pathol       Date:  2015-04-19

Review 9.  Why Do Parotid Pleomorphic Adenomas Recur? A Systematic Review of Pathological and Surgical Variables.

Authors:  Pavel Dulguerov; Jelena Todic; Marc Pusztaszeri; Naif H Alotaibi
Journal:  Front Surg       Date:  2017-05-15

10.  Estrogen Receptor, Progesterone Receptor, and HER-2 Expression in Recurrent Pleomorphic Adenoma.

Authors:  Ana Amélia de Souza; Albina Altemani; Ney Soares de Araujo; Lucas Novaes Texeira; Vera Cavalcanti de Araújo; Andresa Borges Soares
Journal:  Clin Pathol       Date:  2019-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.